Cytosorbents Corp Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cytosorbents Corp (Nasdaq: CTSO) on April 6, 2023, reporting events occurring on March 31, 2023. The filing addresses the retirement of the Chief Financial Officer and the subsequent appointment of an Interim CFO.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive compensation and personnel changes rather than financial performance.
Material Changes
- Executive Departure: Ms. Kathleen P. Bloch retired from her role as Chief Financial Officer effective March 31, 2023.
- Interim Appointment: Ms. Bloch was appointed as Interim Chief Financial Officer and consultant under a new agreement.
- Compensation Structure: The new arrangement includes an hourly rate of $335 for approximately 20 hours of service per week.
- Equity Grant: Ms. Bloch received 20,000 stock options with an exercise price of $3.37 per share, based on the closing price on March 31, 2023.
- Contract Term: The Consulting Agreement is effective until December 31, 2025, unless terminated earlier with 14 days' written notice.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on business outlook, or specific risk factors beyond the standard disclosure of the executive transition. The primary contingency noted is the potential early termination of the consulting agreement by either party.
Key Facts for Investor Verification
- Verify the total annualized cost of the interim CFO arrangement, including hourly fees and the fair value of the 20,000 stock options.
- Confirm the timeline for the search for a permanent Chief Financial Officer.
- Review the full text of the Consulting Agreement (Exhibit 10.1) for any non-compete or confidentiality clauses not summarized in the 8-K.
- Monitor future filings for any changes to the company's financial reporting schedule or internal controls resulting from the leadership transition.